Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Chemical Immunology and Allergy|March 21, 2007
Superantigen-induced regulatory T cells in vivoFredrik IvarsEuropean Journal of Immunology|March 1, 2002
The pT alpha promoter and enhancer are direct targets for transactivation by E box-binding proteinsKarin Petersson, Fredrik Ivars, Mikael SigvardssonEuropean Journal of Immunology|March 14, 2009
T-cell tolerance induced by repeated antigen stimulation: selective loss of Foxp3- conventional CD4 T cells and induction of CD4 T-cell anergyLena Eroukhmanoff, Cecilia Oderup, Fredrik IvarsEndocrine, Metabolic & Immune Disorders Drug Targets|March 17, 2015
S100A9 as a Pharmacological Target Molecule in Inflammation and CancerTomas Leanderson, David Liberg, Fredrik IvarsImmunology|August 24, 2006
T cells developing in fetal thymus of T-cell receptor alpha-chain transgenic mice colonize gammadelta T-cell-specific epithelial niches but lack long-term reconstituting potentialKarin Leandersson, Elin Jaensson, Fredrik IvarsInternational Immunopharmacology|March 11, 2011
Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cellsSofia Helmersson, Martin Stenström, Tomas Leanderson, et al.Biochemical and Biophysical Research Communications|April 22, 2018
Induction of S100A9 homodimer formation in vivoEva Källberg, Sahar Tahvili, Fredrik Ivars, et al.BMC Cancer|July 13, 2016
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growthAdnan Deronic, Sahar Tahvili, Tomas Leanderson, et al.International Immunopharmacology|December 28, 2013
The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: leukocyte- and context-specific effectsAdnan Deronic, Sofia Helmersson, Tomas Leanderson, et al.Pageof 4